Nairobi, Kenya (CU)_ The World Health Organization (WHO) stated that the only licensed malaria vaccine should be widely distributed to African children, making a significant step forward in the fight against a disease that claims the lives of hundreds of thousands of Africans each year. The WHO advises the use of RTS,S or Mosquirix, which is a vaccine produced by the British pharmaceutical company GlaxoSmithKline. The WHO guideline is based on…
